Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2013 1
2014 1
2017 2
2018 1
2020 4
2021 4
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitor-related dermatologic adverse events.
Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DYM, Moy AP, Kern JA, Lacouture ME. Geisler AN, et al. Among authors: barrios dm. J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23. J Am Acad Dermatol. 2020. PMID: 32454097 Free PMC article. Review.
Lingual Papillomas.
Barrios DM, LaDuca JR. Barrios DM, et al. N Engl J Med. 2017 Oct 12;377(15):e22. doi: 10.1056/NEJMicm1700204. N Engl J Med. 2017. PMID: 29020597 Free article. No abstract available.
Immune checkpoint inhibitors to treat cutaneous malignancies.
Barrios DM, Do MH, Phillips GS, Postow MA, Akaike T, Nghiem P, Lacouture ME. Barrios DM, et al. J Am Acad Dermatol. 2020 Nov;83(5):1239-1253. doi: 10.1016/j.jaad.2020.03.131. Epub 2020 May 24. J Am Acad Dermatol. 2020. PMID: 32461079 Free PMC article. Review.
Suggested methodology for longitudinal evaluation of nevi based on clinical images.
Reiter O, Musthaq S, Kurtansky NR, Barrios DM, Halpern AC, Marchetti MA, Marghoob AA, Nanda JK, Stoll J, Rotemberg V. Reiter O, et al. Among authors: barrios dm. Skin Res Technol. 2022 Jan;28(1):71-74. doi: 10.1111/srt.13092. Epub 2021 Aug 29. Skin Res Technol. 2022. PMID: 34455638 Free PMC article.
Dermatologic infections in cancer patients treated with checkpoint inhibitors.
Do MH, Barrios DM, Phillips GS, Postow MA, Warner AB, Rosenberg JE, Noor SJ, Markova A, Lacouture ME. Do MH, et al. Among authors: barrios dm. J Am Acad Dermatol. 2021 Dec;85(6):1528-1536. doi: 10.1016/j.jaad.2021.03.039. Epub 2021 Mar 17. J Am Acad Dermatol. 2021. PMID: 33744355 Free PMC article.
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies.
Barrios DM, Phillips GS, Geisler AN, Trelles SR, Markova A, Noor SJ, Quigley EA, Haliasos HC, Moy AP, Schram AM, Bromberg J, Funt SA, Voss MH, Drilon A, Hellmann MD, Comen EA, Narala S, Patel AB, Wetzel M, Jung JY, Leung DYM, Lacouture ME. Barrios DM, et al. Ann Oncol. 2021 Jun;32(6):736-745. doi: 10.1016/j.annonc.2021.02.016. Epub 2021 Mar 3. Ann Oncol. 2021. PMID: 33667669 Free PMC article.
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer.
Bou Zerdan M, Ashok Kumar P, Barrios DM, Glidden A, Nasr D, Niforatos S, Ghelani G, Leibovitch J, Nasr S, Kc B, Ombada M, Khokhar F, Poudyal B, Bhandari J, Shahnawaz M, Graziano S, Lim SH. Bou Zerdan M, et al. Among authors: barrios dm. Front Oncol. 2023 May 12;13:1134824. doi: 10.3389/fonc.2023.1134824. eCollection 2023. Front Oncol. 2023. PMID: 37251929 Free PMC article.
16 results